Home Tags ContraFect Corp.

Tag: ContraFect Corp.

Yonkers biotech ContraFect announces public offering of common stock

The company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the offering.

ContraFect prices $10M public offering of common stock

The Yonkers biotechnology company priced 5 million shares of common stock at $2.00 per share.

Contrafect appoints Lisa Ricciardi as chief operating officer

Ricciardi will continue to serve in her role as a director of ContraFect.

Contrafect CEO Gilman takes temporary medical leave

Steven C. Gilman Gilman will remain as chairman and is expected to return in the third quarter of 2017, according to the company announcement.

ContraFect teams with China on universal flu drug research

ContraFect Corp. in Yonkers will collaborate with a Chinese health agency to develop the Yonkers biotech company's new treatment for influenza.

ContraFect trading on Nasdaq Capital Market

The Yonkers company prices the units, of which 6 million will be offered, at $6 each, generating $36 million in gross proceeds from the initial public offering.